| Expression pattern: |
UN |
| Associated gene: |
FGFR4 |
| Associated microRNA: |
miR-491 / miR-491-5p |
| Biological function: |
Associated with axillary response to neoadjuvant chemotherapy; higher circRNA level relates to worse therapeutic outcome and promotes FGFR4 expression by sponging miR-491-5p. |
| Molecular mechanism: |
ceRNA mechanism: hsa_circ_0001361 sponges miR-491-5p, relieving repression on FGFR4 and increasing FGFR4 expression. |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; Western Blot; IHC (Immunohistochemistry) |
| Clinical significance: |
Low circRNA expression is associated with better outcome after NAC treatment. |
| Description: |
In breast cancer patients receiving neoadjuvant chemotherapy, lower hsa_circ_0001361 expression is associated with better axillary response. Mechanistically, hsa_circ_0001361 acts as a sponge for miR-491-5p, leading to increased FGFR4 expression. |
| Confidence score: |
0.6765 |